John Harrison Krystal
Overview
Explore the profile of John Harrison Krystal including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
853
Followers
0
Related Specialty
Related Specialty
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chekroud A, Zotti R, Shehzad Z, Gueorguieva R, Johnson M, Trivedi M, et al.
Lancet Psychiatry
. 2016 Jan;
3(3):243-50.
PMID: 26803397
Background: Antidepressant treatment efficacy is low, but might be improved by matching patients to interventions. At present, clinicians have no empirically validated mechanisms to assess whether a patient with depression...
2.
Gueorguieva R, Wu R, Donovan D, Rounsaville B, Couper D, Krystal J, et al.
Alcohol
. 2011 Sep;
46(2):121-31.
PMID: 21925828
The Combined Pharmacotherapies and Behavioral Interventions (COMBINE) Study sought to answer questions about the benefits of combining behavioral and pharmacological interventions (naltrexone and acamprosate) in alcohol-dependent patients. Our goals were...
3.
Luteal-phase accentuation of acoustic startle response in women with premenstrual dysphoric disorder
Epperson C, Pittman B, Czarkowski K, Stiklus S, Krystal J, Grillon C
Neuropsychopharmacology
. 2007 Feb;
32(10):2190-8.
PMID: 17314917
Alterations in central nervous system response to menstrual cycle-related fluctuations in neuroactive steroids are thought to underlie the emergence of negative affect in the luteal phase of the menstrual cycle...
4.
DSouza D, Abi-Saab W, Madonick S, Forselius-Bielen K, Doersch A, Braley G, et al.
Biol Psychiatry
. 2005 Mar;
57(6):594-608.
PMID: 15780846
Background: Recent advances in the neurobiology of cannabinoids have renewed interest in the association between cannabis and psychotic disorders. Methods: In a 3-day, double-blind, randomized, placebo-controlled study, the behavioral, cognitive,...
5.
DSouza D, Perry E, Macdougall L, Ammerman Y, Cooper T, Wu Y, et al.
Neuropsychopharmacology
. 2004 Jun;
29(8):1558-72.
PMID: 15173844
Recent advances in the understanding of brain cannabinoid receptor function have renewed interest in the association between cannabinoid compounds and psychosis. In a 3-day, double-blind, randomized, and counterbalanced study, the...